{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:20:54Z","timestamp":1758817254189},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.iac.2005.02.003","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T22:49:06Z","timestamp":1115419746000},"page":"283-299","source":"Crossref","is-referenced-by-count":19,"title":["Pediatric Allergic Rhinitis: Treatment"],"prefix":"10.1016","volume":"25","author":[{"given":"Lien","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas B.","family":"Casale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2005.02.003_bib1","series-title":"US Department of Health and Human Services Publication #97-1522","first-page":"1","article-title":"Prevalence of selected chronic conditions: United States, 1990\u20131992","author":"Collins","year":"1997"},{"issue":"5","key":"10.1016\/j.iac.2005.02.003_bib2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib3","series-title":"Middleton's allergy: principles and practice","first-page":"1599","article-title":"Allergic and immunologic diseases of the eye","author":"Barney","year":"2003"},{"key":"10.1016\/j.iac.2005.02.003_bib4","series-title":"The allergy report. Allergic disorders: promoting best practices","year":"2001"},{"issue":"5","key":"10.1016\/j.iac.2005.02.003_bib5","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma: ARIA guidelines","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2005.02.003_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3038.1997.tb00156.x","article-title":"Worldwide variations in prevalence of symptoms of allergic rhino-conjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC)","volume":"8","author":"Strachan","year":"1997","journal-title":"Pediatr Allergy Immunol"},{"issue":"5 Pt 2","key":"10.1016\/j.iac.2005.02.003_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S1081-1206(10)63155-9","article-title":"Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology","volume":"81","author":"Dykewicz","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/pai.1998.12.1","article-title":"Differential impacts of allergic rhinitis and allergy medications on childhood learning","volume":"12","author":"Bender","year":"1998","journal-title":"Pediatr Asthma Allergy Immunol"},{"issue":"6 Pt 2","key":"10.1016\/j.iac.2005.02.003_bib9","doi-asserted-by":"crossref","first-page":"S616","DOI":"10.1067\/mai.2000.106152","article-title":"Therapeutic approaches to allergic rhinitis: treating the child","volume":"105","author":"Fireman","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2005.02.003_bib10","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1067\/mai.2001.115562","article-title":"Pediatric allergic rhinitis and comorbid disorders","volume":"108","author":"Lack","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1081-1206(10)62612-9","article-title":"National guidelines needed to manage rhinitis and prevent complications","volume":"82","author":"Rachelefsky","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2005.02.003_bib12","first-page":"S235","article-title":"Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis","author":"Tanner","year":"1999","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.iac.2005.02.003_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2005.02.003_bib14","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1067\/mai.2001.115566","article-title":"Quality of life in adults and children with allergic rhinitis","volume":"108","author":"Meltzer","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1046\/j.1365-2222.2003.01766.x","article-title":"Rhinitis in pre-school children: prevalence, association with allergic diseases and risk factors","volume":"33","author":"Peroni","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2005.02.003_bib16","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mai.2001.115569","article-title":"Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis","volume":"108","author":"Skoner","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib17","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/S0091-6749(99)70308-8","article-title":"Pathophysiology of the inflammatory response","volume":"104","author":"Pearlman","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2005.02.003_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2165\/00063030-200115070-00004","article-title":"Clinical prescribing of allergic rhinitis medication in the preschool and young school-age child: what are the options?","volume":"15","author":"Galant","year":"2001","journal-title":"BioDrugs"},{"issue":"2 Pt 2","key":"10.1016\/j.iac.2005.02.003_bib19","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1016\/S0091-6749(98)70223-4","article-title":"Special considerations for the child with airway disease","volume":"101","author":"Smith","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa023171","article-title":"Evaluation of impermeable covers for bedding in patients with allergic rhinitis","volume":"349","author":"Terreehorst","year":"2003","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.iac.2005.02.003_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJMoa032097","article-title":"Results of a home-based environmental intervention among urban children with asthma","volume":"351","author":"Morgan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.iac.2005.02.003_bib22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1034\/j.1398-9995.2002.23625.x","article-title":"Workshop Expert Panel. Allergic Rhinitis and its Impact on Asthma (ARIA): executive summary of the workshop report","volume":"57","author":"Bousquet","year":"2002","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2005.02.003_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1034\/j.1398-9995.2000.00526.x","article-title":"Consensus statement on the treatment of allergic rhinitis","volume":"55","author":"Van Cauwenberge","year":"2000","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2005.02.003_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/000992289803700101","article-title":"Treatment options for the child with allergic rhinitis","volume":"37","author":"Meltzer","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.iac.2005.02.003_bib25","first-page":"121","article-title":"Seasonal allergic rhinitis and antihistamine effects on children's learning","volume":"71","author":"Vuurman","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.iac.2005.02.003_bib26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1081-1206(10)63230-9","article-title":"Adverse effects of medications for rhinitis","volume":"78","author":"Milgrom","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2005.02.003_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1067\/mai.2003.1384","article-title":"Fexofenadine is efficacious and safe in children (aged 6\u201311 years) with seasonal allergic rhinitis","volume":"111","author":"Wahn","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2005.02.003_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mai.2003.168","article-title":"Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis","volume":"111","author":"Simons","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2005.02.003_bib29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/000992280204100908","article-title":"The health-related quality of life effects of once-daily cetirizine HCl syrup in children with seasonal allergic rhinitis","volume":"41","author":"Gillman","year":"2002","journal-title":"Clin Pediatr (Phila)"},{"issue":"2 Pt 1","key":"10.1016\/j.iac.2005.02.003_bib30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0091-6749(89)90127-9","article-title":"Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis","volume":"83","author":"Bruttmann","year":"1989","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2005.02.003_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1081-1206(10)62317-4","article-title":"Safety of fexofenadine in children treated for seasonal allergic rhinitis","volume":"87","author":"Graft","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2005.02.003_bib32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1399-3038.2004.00167.x","article-title":"Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis\u2014a pooled analysis of three studies","volume":"15","author":"Meltzer","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2005.02.003_bib33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1365-2222.2000.00914.x","article-title":"Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis","volume":"30","author":"Van Cauwenberge","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2005.02.003_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/pai.1996.10.9","article-title":"Treatment of seasonal allergic rhinitis in children with cetirizine and chlorpheniramine. A multi-center study","volume":"10","author":"Tinkel","year":"1996","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib35","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/BF03259210","article-title":"Cetirizine in children with chronic allergic rhinitis","volume":"4","author":"Baelde","year":"1992","journal-title":"Drug Invest"},{"issue":"2","key":"10.1016\/j.iac.2005.02.003_bib36","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1542\/peds.113.2.e116","article-title":"Central nervous system side effects of first- and second-generation antihistamines in school children with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled comparative study","volume":"113","author":"Ng","year":"2004","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.iac.2005.02.003_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1081-1206(10)61682-1","article-title":"Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis","volume":"91","author":"Hampel","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2005.02.003_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5876(96)01457-7","article-title":"A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis","volume":"39","author":"Herman","year":"1997","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"2","key":"10.1016\/j.iac.2005.02.003_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1081-1206(10)61468-8","article-title":"Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine","volume":"93","author":"LaForce","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib40","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1067\/mai.2000.106153","article-title":"The effects of antihistamines on cognition and performance","volume":"105","author":"Kay","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1081-1206(10)62085-6","article-title":"Intranasal corticosteroids versus topical H receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis","volume":"89","author":"Y\u00e1\u00f1ez","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib42","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1067\/mai.2000.110038","article-title":"Systemic effects of intranasal steroids: an endocrinologist's perspective","volume":"106","author":"Allen","year":"2000","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"10.1016\/j.iac.2005.02.003_bib43","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1542\/peds.112.1.96","article-title":"Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients","volume":"112","author":"Galant","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.iac.2005.02.003_bib44","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1067\/mai.2001.115568","article-title":"Corticosteroids in the treatment of pediatric allergic rhinitis","volume":"108","author":"Scadding","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib45","doi-asserted-by":"crossref","unstructured":"Skoner D.P., Rachelefsky G.S., Meltzer E.O., et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105(2):E23, 1\u20137","DOI":"10.1542\/peds.105.2.e23"},{"key":"10.1016\/j.iac.2005.02.003_bib46","doi-asserted-by":"crossref","unstructured":"Schenkel E.J., Skoner D.P., Bronsky E.A., et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000;105(2):E22, 1\u20137","DOI":"10.1542\/peds.105.2.e22"},{"key":"10.1016\/j.iac.2005.02.003_bib47","first-page":"407","article-title":"No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year","volume":"23","author":"Allen","year":"2002","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2005.02.003_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1081-1206(10)63615-0","article-title":"The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis","volume":"90","author":"Skoner","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib49","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2222.2003.01689.x","article-title":"Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis","volume":"33","author":"Moller","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2005.02.003_bib50","doi-asserted-by":"crossref","unstructured":"Skoner D.P., Gentile D.A., Doyle W.J., et al. Effect of 1-year treatment with triamcinolone acetonide aqueous (TAA) nasal spray on growth velocity and HPA function in children with allergic rhinitis [abstract 39]. In: Programs and abstracts of the annual meeting of the American College of Allergy Asthma and Immunology. Boston, November 12\u201317, 2004. p.12","DOI":"10.1016\/j.jaci.2004.12.1077"},{"issue":"6","key":"10.1016\/j.iac.2005.02.003_bib51","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2222.2003.01689.x","article-title":"Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis","volume":"33","author":"Moller","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.iac.2005.02.003_bib52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.4065\/77.4.350","article-title":"Use of intranasal cromolyn sodium for allergic rhinitis","volume":"77","author":"Ratner","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"Suppl","key":"10.1016\/j.iac.2005.02.003_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1081-1206(10)62025-X","article-title":"Clinical evidence for antileukotriene therapy in the management of allergic rhinitis","volume":"88","author":"Meltzer","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2005.02.003_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1081-1206(10)62144-8","article-title":"Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis","volume":"90","author":"Van Adelsberg","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"10.1016\/j.iac.2005.02.003_bib55","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2222.2002.01422.x","article-title":"Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring","volume":"32","author":"Philip","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2005.02.003_bib56","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1046\/j.1398-9995.2003.00261.x","article-title":"Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period","volume":"58","author":"Van Adelsberg","year":"2003","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2005.02.003_bib57","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1081-1206(10)61576-1","article-title":"Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies","volume":"92","author":"Chervinsky","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2005.02.003_bib58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1517\/14656566.5.3.679","article-title":"A review of montelukast in the treatment of asthma and allergic rhinitis","volume":"5","author":"Nayak","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.iac.2005.02.003_bib59","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1081-1206(10)61891-1","article-title":"Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall","volume":"88","author":"Nayak","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1081-1206(10)62138-2","article-title":"Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments","volume":"90","author":"Nathan","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2005.02.003_bib61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)63236-X","article-title":"Ipratropium nasal spray in children with perennial rhinitis","volume":"78","author":"Meltzer","year":"1997","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2005.02.003_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.1998.tb04930.x","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic disease: WHO position paper","volume":"53","author":"Bousquet","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2005.02.003_bib63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0149-2918(00)80038-7","article-title":"Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: an analysis of randomized, prospective, single- or double-blind, placebo-controlled studies","volume":"22","author":"Ross","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.iac.2005.02.003_bib64","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00008480-200012000-00011","article-title":"Immunotherapy of asthma and allergic diseases","volume":"12","author":"TePas","year":"2000","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"10.1016\/j.iac.2005.02.003_bib65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"109","author":"Moller","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2005.02.003_bib66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003495-200161030-00005","article-title":"Does allergen immunotherapy alter the natural course of allergic disorders?","volume":"61","author":"Yang","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.iac.2005.02.003_bib67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)62171-0","article-title":"Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis","volume":"91","author":"Chervinsky","year":"2003","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856105000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856105000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:08:07Z","timestamp":1683090487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856105000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0889856105000044"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2005.02.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}